News
SNYNF
95.91
+2.58%
2.41
Merck KgaA's New CEO Kai Beckmann Takes Charge As Belén Garijo Becomes Sanofi CEO
NASDAQ · 22h ago
Regeneron price target lowered to $762 from $779 at RBC Capital
TipRanks · 1d ago
Regeneron drops despite Q1 beat, $3B share buyback program
Seeking Alpha · 2d ago
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease
TipRanks · 3d ago
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC) and Sanofi (OtherSNYNF)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Janux Therapeutics Inc (JANX)
TipRanks · 3d ago
Recursion Pharmaceuticals May Be Losing Ground To Its Peers
Seeking Alpha · 4d ago
Weekly Report: what happened at SNYNF last week (0420-0424)?
Weekly Report · 4d ago
Sanofi Prices EUR 2.3 Bln Notes Offering Across Three Tranches
NASDAQ · 4d ago
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Sanofi (OtherSNYNF)
TipRanks · 04/25 01:40
UBS Keeps Their Hold Rating on Sanofi (SNYNF)
TipRanks · 04/24 12:25
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF) and Medpace Holdings (MEDP)
TipRanks · 04/24 11:40
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)
TipRanks · 04/24 10:00
Sanofi Advances Amlitelimab Program With Key Drug-Interaction Study Completion
TipRanks · 04/23 16:30
Analysts Conflicted on These Healthcare Names: BridgeBio Oncology Therapeutics (BBOT), Sanofi (OtherSNYNF) and Molina Healthcare (MOH)
TipRanks · 04/23 14:40
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)
TipRanks · 04/23 11:21
Sanofi reports Q1 business EPS EUR 1.88, up 5% reported
TipRanks · 04/23 10:23
Sanofi expects FY26 sales to grow by high single-digit percentage at CER
TipRanks · 04/23 10:21
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and Sanofi (OtherSNYNF)
TipRanks · 04/23 10:20
More
Webull provides a variety of real-time SNYNF stock news. You can receive the latest news about Sanofi FR through multiple platforms. This information may help you make smarter investment decisions.
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.